Acute effects of pharmacological modifications of fatty acid metabolism on human satiety
The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( − )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured i...
Gespeichert in:
| Veröffentlicht in: | British journal of nutrition Jg. 101; H. 12; S. 1867 - 1877 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Cambridge, UK
Cambridge University Press
28.06.2009
|
| Schlagworte: | |
| ISSN: | 0007-1145, 1475-2662, 1475-2662 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( − )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, β-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P < 0·05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0·71, P < 0·01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r − 0·75, P < 0·0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. |
|---|---|
| AbstractList | The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( - )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, beta-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P < 0.05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0.71, P < 0.01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r - 0.75, P < 0.0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or (-)-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320mg), HCA (2g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, beta -hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P<0.05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0.71, P<0.01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r -0.75, P<0.0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( - )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, beta-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P < 0.05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0.71, P < 0.01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r - 0.75, P < 0.0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation.The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( - )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, beta-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P < 0.05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0.71, P < 0.01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r - 0.75, P < 0.0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( - )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, β-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P < 0·05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0·71, P < 0·01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r - 0·75, P < 0·0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( − )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, β-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 ( se 23) min ( P < 0·05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments ( r 2 0·71, P < 0·01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal ( r − 0·75, P < 0·0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( - )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, β-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P < 0·05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0·71, P < 0·01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r - 0·75, P < 0·0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. [PUBLICATION ABSTRACT] The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( − )-hydroxycitrate (HCA), an inhibitor of lipogenesis which may indirectly stimulate NEFA oxidation, alters satiety. Post-lunch satiety was measured in eight normal-weight male subjects who were deprived of time cues and received on three occasions either ETO (320 mg), HCA (2 g) or placebo (PLA) in random order. Between lunch and dinner, blood was withdrawn continuously and collected every 10 min for measures of plasma concentrations of glucose, insulin, lactate, TAG, NEFA, β-hydroxybutyrate (BHB), leptin and ghrelin. Results showed that HCA began to decrease hunger and desire to eat compared to PLA and ETO 210 min after lunch and increased satiety duration compared to PLA by 70 (se 23) min (P < 0·05), but did not modify energy intake at dinner. ETO did not affect any variable of satiety. HCA increased NEFA concentrations during the pre-dinner period, whereas ETO increased and decreased plasma concentrations of NEFA and BHB, respectively. Mean differences in plasma NEFA concentrations between HCA and PLA were predictive of the differences in satiety duration between treatments (r2 0·71, P < 0·01). Among treatments, plasma leptin concentration at dinner onset was the only blood variable correlated with energy intake at this meal (r − 0·75, P < 0·0005). In healthy, normal-weight men, acute HCA increased the intensity and duration of satiety possibly via increased NEFA disposal for oxidation. |
| Author | Aubert, Roberte Arnold, Myrtha Chapelot, Didier Zuberbuehler, Christine Gatta, Blandine Langhans, Wolfgang |
| Author_xml | – sequence: 1 givenname: Blandine surname: Gatta fullname: Gatta, Blandine organization: 1Service d'Endocrinologie et Maladies Métaboliques, Hôpital du Haut Lévêque, Pessac, 33604, France – sequence: 2 givenname: Christine surname: Zuberbuehler fullname: Zuberbuehler, Christine organization: 2Physiology and Behaviour Group, Institute of Animal Sciences, ETH Zurich, Schorerstrasse 16, 8603 Schwerzerbach, Switzerland – sequence: 3 givenname: Myrtha surname: Arnold fullname: Arnold, Myrtha organization: 2Physiology and Behaviour Group, Institute of Animal Sciences, ETH Zurich, Schorerstrasse 16, 8603 Schwerzerbach, Switzerland – sequence: 4 givenname: Roberte surname: Aubert fullname: Aubert, Roberte organization: 3Université Paris 7, INSERM U695, Faculté Xavier Bichat, 75018Paris, France – sequence: 5 givenname: Wolfgang surname: Langhans fullname: Langhans, Wolfgang organization: 2Physiology and Behaviour Group, Institute of Animal Sciences, ETH Zurich, Schorerstrasse 16, 8603 Schwerzerbach, Switzerland – sequence: 6 givenname: Didier surname: Chapelot fullname: Chapelot, Didier email: comp-alim@smbh.univ-paris13.fr organization: 4Université Paris 13, Réponses Cellulaires et Fonctionnelles à l'Hypoxie, EA 2363, UFR Santé Médecine et Biologie Humaine, 93017Bobigny Cedex, France |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21668512$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19079943$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkkFv1DAQhSNURLeFH8AFIiS4BTyxYzvHqqItUiUEpRI3a-LYW5ckXmxHYv99vd1lkYqgJ9ua71lv3sxRcTD5yRTFSyDvgYD4cEUIEQCsIRIY5YQ9KRbARFPVnNcHxWJTrjb1w-Ioxtv8lEDaZ8UhtES0LaOL4vuJnpMpjbVGp1h6W65uMIyo_eCXTuNQjr53Nt-S89M9YDGldYna9eVoEnZ-cHEs_VTezCNOZcykSevnxVOLQzQvdudxcX328dvpRXX5-fzT6cllpRsuUgVctwb7WtSEM47GMsk6rY1Gi620lvTSskZSbXjXEjC0q3mt-6ZFYSRKTY-Ld9t_V8H_nE1ManRRm2HAyfg5Ki4YtIKyR0HGKRPA4VEwO5VCcJ7BNw_AWz-HKXeraqCS5rQ3v73aQXM3ml6tghsxrNXvEWTg7Q7AmPO2ASft4p6rgXPZQJ05seV08DEGY5V26X4qKaAbFBC1WQr111JkJTxQ7k38R1NtNS4m82svwPAjJ0pFo_j5l9zDV9ZctExtsni95S16hcuQO7i-qglQArwRFGQm6M4Fjl1w_dL8ievfPu4AcPHeEg |
| CODEN | BJNUAV |
| CitedBy_id | crossref_primary_10_1021_jm100809g crossref_primary_10_1139_apnm_2018_0485 crossref_primary_10_1016_j_appet_2012_02_041 crossref_primary_10_1186_1743_7075_8_66 crossref_primary_10_1017_S000711450999225X crossref_primary_10_1016_j_metabol_2018_11_012 crossref_primary_10_3390_nu13020549 crossref_primary_10_1097_MCO_0b013e3283437b78 crossref_primary_10_1017_S0954422420000062 crossref_primary_10_1016_j_jhep_2018_04_004 crossref_primary_10_3390_ijms222111537 crossref_primary_10_1080_10408398_2010_500551 crossref_primary_10_1007_s00394_016_1347_1 crossref_primary_10_2165_11588780_000000000_00000 crossref_primary_10_1002_wsbm_1226 crossref_primary_10_1016_j_appet_2012_07_003 |
| Cites_doi | 10.1007/BF03344045 10.1093/ajcn/72.2.421 10.2337/diabetes.50.8.1714 10.1001/jama.280.18.1596 10.1093/ajcn/76.1.141 10.1016/S0021-9258(19)86870-9 10.1016/j.physbeh.2003.12.006 10.1093/ajcn/65.5.1410 10.1093/ajcn/76.3.518 10.1017/S0007114599001671 10.1016/j.metabol.2007.04.006 10.1093/jn/130.12.2990 10.1055/s-2007-979072 10.1016/S0021-9258(17)41006-4 10.2105/AJPH.86.5.726 10.1136/bmj.300.6719.230 10.1001/jama.291.23.2847 10.1093/jn/132.7.1977 10.3177/jnsv.49.163 10.1016/0149-7634(80)90040-8 10.1016/0091-3057(77)90095-8 10.1038/sj.ijo.0803001 10.1093/ajcn/72.6.1445 10.1023/A:1019911205672 10.1016/S0031-9384(99)00176-6 10.1016/j.physbeh.2004.03.021 10.1006/abio.2001.5046 10.1016/j.nut.2004.06.012 10.1016/j.neulet.2006.10.034 10.1038/sj.ijo.0801605 10.1016/0003-9861(72)90025-2 10.1007/BF02532137 10.1016/S0031-9384(00)00321-8 10.1016/S0031-9384(01)00547-9 10.1016/j.metabol.2006.08.024 10.1016/S0031-9384(01)00594-7 10.1038/oby.2006.28 10.3727/000000003783992289 10.1111/j.1462-8902.2004.00328.x 10.1089/dna.2007.0617 10.1016/0031-9384(87)90010-2 10.1016/S0899-9007(99)00212-9 10.1016/0031-9384(91)90326-J 10.1016/S0163-1047(87)90112-9 10.1271/bbb.67.1999 10.1038/sj.ijo.0800965 10.1016/j.physbeh.2006.04.005 10.1152/ajpgi.00428.2004 10.1093/ajcn/62.5.1107S 10.1152/ajpendo.00582.2003 10.1017/S0007114507659054 10.1017/S0007114599001695 10.3177/jnsv.48.128 10.1038/sj.ijo.0801979 |
| ContentType | Journal Article |
| Copyright | Copyright © The Authors 2008 2009 INIST-CNRS |
| Copyright_xml | – notice: Copyright © The Authors 2008 – notice: 2009 INIST-CNRS |
| DBID | FBQ BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7T5 7X2 7X7 7XB 88E 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB0 M0K M0S M1P M2O MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7U7 C1K 7S9 L.6 7X8 |
| DOI | 10.1017/S0007114508143604 |
| DatabaseName | AGRIS Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Immunology Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Agricultural Science Database ProQuest Health & Medical Collection Medical Database ProQuest Research Library Research Library (Corporate) Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic Toxicology Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) Toxicology Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Toxicology Abstracts MEDLINE - Academic AGRICOLA CrossRef Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Diet & Clinical Nutrition |
| DocumentTitleAlternate | Fatty acid metabolism and satiety in man B. Gatta et al. |
| EISSN | 1475-2662 |
| EndPage | 1877 |
| ExternalDocumentID | 1801523351 19079943 21668512 10_1017_S0007114508143604 ark_67375_6GQ_19R45H94_6 US201301657318 |
| Genre | Randomized Controlled Trial Journal Article Comparative Study |
| GroupedDBID | --- -E. -~X .FH 09C 09E 0E1 0R~ 23N 2WC 3EH 3V. 4.4 5GY 5RE 5VS 6J9 6PF 74X 74Y 7RV 7X2 7X7 7~V 88E 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 9M5 AAAZR AABES AABWE AACJH AAFWJ AAGFV AAHBH AAIKC AAKTX AAMNQ AAMNW AARAB AASVR AATID AATMM AAUIS AAUKB AAWTL AAZAQ ABBJB ABBXD ABFBI ABGDZ ABJNI ABKKG ABKMT ABMWE ABQTM ABROB ABUWG ABVKB ABVZP ABWCF ABXAU ABZCX ABZUI ACBEK ACBMC ACDLN ACGFS ACIMK ACPRK ACRPL ACUIJ ACYZP ACZBM ACZUX ACZWT ADAZD ADBBV ADDNB ADFEC ADFRT ADKIL ADNMO ADVJH AEBAK AEHGV AEMFK AEMTW AENEX AENGE AEPLO AEUYN AEYHU AEYYC AFFNX AFFUJ AFKQG AFKRA AFLOS AFLVW AFOSN AFRAH AFRIC AFUTZ AFZFC AGABE AGJUD AHIPN AHLTW AHMBA AHQXX AHRGI AIGNW AIHIV AIOIP AISIE AJ7 AJCYY AJPFC AJQAS ALMA_UNASSIGNED_HOLDINGS ALWZO AN0 ANPSP AQJOH ATCPS ATUCA AUXHV AZGZS AZQEC BAWUL BBLKV BENPR BHPHI BKEYQ BLZWO BNQBC BPHCQ BQFHP BRIRG BVXVI C0O C1A CAG CBIIA CCPQU CCQAD CFAFE CHEAL CJCSC COF CS3 DIK DOHLZ DU5 DWQXO E3Z EBS EJD EX3 F5P FYUFA GNUQQ GUQSH HCIFZ HG- HH5 HMCUK HZ~ I.6 IH6 IOEEP IOO IS6 I~P J36 J38 J3A JHPGK JKPOH JQKCU JVRFK KCGVB KFECR L7B L98 LW7 M-V M0K M1P M2O M7~ NAPCQ NIKVX O9- OK1 OVD P6G PCD PQQKQ PROAC PSQYO Q2X RAMDC RCA RIG ROL RR0 S6- S6U SAAAG SJN SY4 T9M TEORI TR2 UCJ UKHRP UT1 UU6 WFFJZ WH7 WOW WQ3 WXU WYP Y6R ZMEZD ZYDXJ ~KM -1D -1F -2P -2V -~6 -~N .55 .GJ 354 3O- 53G 6~7 AANRG AAYJJ ABBZL ABHFL ABVFV ACEJA ACETC ACOZI ADOVH ADOVT AEBPU AENCP AGKLZ AGLWM AI. AKZCZ ALEEW ANOYL ARABE ARZZG AYIQA BCGOX BESQT BGHMG BJBOZ BMAJL CCUQV CDIZJ CFBFF CGQII EGQIC FBQ HST I.7 I.9 KAFGG LHUNA M8. NMFBF NZEOI OHT PHGZT UAP VH1 X7M ZCG ZDLDU ZGI ZJOSE ZXP ~V1 ABXHF AGQPQ AKMAY BSCLL PHGZM PJZUB PPXIY PUEGO AAYXX ABUFD AEMTJ AFFHD CITATION AAKNA IQODW CGR CUY CVF ECM EIF NPM 7QP 7T5 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI Q9U 7U7 C1K 7S9 L.6 7X8 |
| ID | FETCH-LOGICAL-c567t-16c9ead2720646aef484bccecafa98ff0d8f4583ce6b901e3b262cd59a7e8a8c3 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 23 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000267772500020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-1145 1475-2662 |
| IngestDate | Fri Sep 05 12:12:09 EDT 2025 Sun Nov 09 09:13:48 EST 2025 Tue Oct 07 09:31:54 EDT 2025 Wed Oct 29 02:46:54 EDT 2025 Mon Jul 21 05:58:05 EDT 2025 Mon Jul 21 09:13:58 EDT 2025 Sat Nov 29 05:55:53 EST 2025 Tue Nov 18 21:16:54 EST 2025 Sun Aug 31 06:48:35 EDT 2025 Thu Apr 03 09:46:21 EDT 2025 Tue Jan 21 06:22:46 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | Fatty acid oxidation Eating ( − )-Hydroxycitrate NEFA Leptin Human Modification Acute Lipids Metabolism Fatty acids Vertebrata Mammalia (―)-Hydroxycitrate Satiety Oxidation |
| Language | English |
| License | https://www.cambridge.org/core/terms CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c567t-16c9ead2720646aef484bccecafa98ff0d8f4583ce6b901e3b262cd59a7e8a8c3 |
| Notes | http://dx.doi.org/10.1017/S0007114508143604 ark:/67375/6GQ-19R45H94-6 ArticleID:14360 istex:ACBEAA3ACF9490211708C49FA621E7D57326AA3B PII:S0007114508143604 Abbreviations: AUC, area under the curve; BHB, β-hydroxybutyrate; ETO, etomoxir; HCA, ( − )-hydroxycitrate; IMI, inter-meal interval; PLA, placebo ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1D568AF951FB2C8B447B6659C2D591E6/S0007114508143604a.pdf/div-class-title-acute-effects-of-pharmacological-modifications-of-fatty-acid-metabolism-on-human-satiety-div.pdf |
| PMID | 19079943 |
| PQID | 213830811 |
| PQPubID | 5629 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_67419734 proquest_miscellaneous_46347161 proquest_miscellaneous_20687766 proquest_journals_213830811 pubmed_primary_19079943 pascalfrancis_primary_21668512 crossref_citationtrail_10_1017_S0007114508143604 crossref_primary_10_1017_S0007114508143604 istex_primary_ark_67375_6GQ_19R45H94_6 fao_agris_US201301657318 cambridge_journals_10_1017_S0007114508143604 |
| PublicationCentury | 2000 |
| PublicationDate | 2009-06-28 |
| PublicationDateYYYYMMDD | 2009-06-28 |
| PublicationDate_xml | – month: 06 year: 2009 text: 2009-06-28 day: 28 |
| PublicationDecade | 2000 |
| PublicationPlace | Cambridge, UK |
| PublicationPlace_xml | – name: Cambridge, UK – name: Cambridge – name: England |
| PublicationTitle | British journal of nutrition |
| PublicationTitleAlternate | Br J Nutr |
| PublicationYear | 2009 |
| Publisher | Cambridge University Press |
| Publisher_xml | – name: Cambridge University Press |
| References | S0007114508143604_ref60 Preuss (S0007114508143604_ref21) 2004; 35 Pudel (S0007114508143604_ref15) 1989 Sullivan (S0007114508143604_ref10) 1977; 252 S0007114508143604_ref18 Preuss (S0007114508143604_ref20) 2005; 25 S0007114508143604_ref19 S0007114508143604_ref9 S0007114508143604_ref7 S0007114508143604_ref56 S0007114508143604_ref12 S0007114508143604_ref57 S0007114508143604_ref13 S0007114508143604_ref54 S0007114508143604_ref55 S0007114508143604_ref6 S0007114508143604_ref3 S0007114508143604_ref16 S0007114508143604_ref17 S0007114508143604_ref58 Greenwood (S0007114508143604_ref35) 1981; 240 S0007114508143604_ref1 S0007114508143604_ref14 S0007114508143604_ref59 S0007114508143604_ref2 S0007114508143604_ref30 S0007114508143604_ref31 S0007114508143604_ref29 S0007114508143604_ref23 S0007114508143604_ref24 S0007114508143604_ref22 S0007114508143604_ref27 S0007114508143604_ref28 S0007114508143604_ref25 S0007114508143604_ref26 S0007114508143604_ref41 S0007114508143604_ref42 S0007114508143604_ref40 McGarry (S0007114508143604_ref11) 1979; 254 S0007114508143604_ref34 S0007114508143604_ref33 S0007114508143604_ref38 S0007114508143604_ref39 S0007114508143604_ref36 S0007114508143604_ref37 Melanson (S0007114508143604_ref32) 1999; 82 Zurlo (S0007114508143604_ref8) 1990; 259 Friedman (S0007114508143604_ref5) 1986; 251 S0007114508143604_ref52 S0007114508143604_ref53 S0007114508143604_ref50 S0007114508143604_ref51 S0007114508143604_ref45 Louis-Sylvestre (S0007114508143604_ref4) 1999; 82 S0007114508143604_ref46 S0007114508143604_ref43 S0007114508143604_ref44 S0007114508143604_ref49 S0007114508143604_ref47 S0007114508143604_ref48 |
| References_xml | – ident: S0007114508143604_ref2 doi: 10.1007/BF03344045 – ident: S0007114508143604_ref14 doi: 10.1093/ajcn/72.2.421 – volume-title: Fragebogen zum Essverhalten (FEV) year: 1989 ident: S0007114508143604_ref15 – ident: S0007114508143604_ref55 doi: 10.2337/diabetes.50.8.1714 – ident: S0007114508143604_ref42 doi: 10.1001/jama.280.18.1596 – ident: S0007114508143604_ref17 doi: 10.1093/ajcn/76.1.141 – volume: 254 start-page: 8163 year: 1979 ident: S0007114508143604_ref11 article-title: In support of the roles of malonyl-CoA and carnitine acyltransferase I in the regulation of hepatic fatty acid oxidation and ketogenesis publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)86870-9 – ident: S0007114508143604_ref16 doi: 10.1016/j.physbeh.2003.12.006 – ident: S0007114508143604_ref30 doi: 10.1093/ajcn/65.5.1410 – ident: S0007114508143604_ref29 doi: 10.1093/ajcn/76.3.518 – volume: 82 start-page: 427 year: 1999 ident: S0007114508143604_ref4 article-title: Glucose utilization dynamics and food intake publication-title: Br J Nutr doi: 10.1017/S0007114599001671 – ident: S0007114508143604_ref7 doi: 10.1016/j.metabol.2007.04.006 – ident: S0007114508143604_ref45 doi: 10.1093/jn/130.12.2990 – volume: 35 start-page: 33 year: 2004 ident: S0007114508143604_ref21 article-title: An overview of the safety and efficacy of a novel, natural ( − )-hydroxycitric acid extract (HCA-SX) for weight management publication-title: J Med – ident: S0007114508143604_ref18 doi: 10.1055/s-2007-979072 – volume: 252 start-page: 7583 year: 1977 ident: S0007114508143604_ref10 article-title: Reactivity and inhibitor potential of hydroxycitrate isomers with citrate synthase, citrate lyase, and ATP citrate lyase publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)41006-4 – ident: S0007114508143604_ref27 doi: 10.2105/AJPH.86.5.726 – ident: S0007114508143604_ref26 doi: 10.1136/bmj.300.6719.230 – ident: S0007114508143604_ref1 doi: 10.1001/jama.291.23.2847 – ident: S0007114508143604_ref39 doi: 10.1093/jn/132.7.1977 – ident: S0007114508143604_ref50 doi: 10.3177/jnsv.49.163 – ident: S0007114508143604_ref33 doi: 10.1016/0149-7634(80)90040-8 – ident: S0007114508143604_ref28 doi: 10.1016/0091-3057(77)90095-8 – volume: 240 start-page: E72 year: 1981 ident: S0007114508143604_ref35 article-title: Effect of ( − )-hydroxycitrate on development of obesity in the Zucker obese rat publication-title: Am J Physiol – ident: S0007114508143604_ref54 doi: 10.1038/sj.ijo.0803001 – ident: S0007114508143604_ref47 doi: 10.1093/ajcn/72.6.1445 – ident: S0007114508143604_ref59 doi: 10.1023/A:1019911205672 – ident: S0007114508143604_ref24 doi: 10.1016/S0031-9384(99)00176-6 – ident: S0007114508143604_ref40 doi: 10.1016/j.physbeh.2004.03.021 – ident: S0007114508143604_ref22 doi: 10.1006/abio.2001.5046 – ident: S0007114508143604_ref37 doi: 10.1016/j.nut.2004.06.012 – ident: S0007114508143604_ref9 doi: 10.1016/j.neulet.2006.10.034 – ident: S0007114508143604_ref44 doi: 10.1038/sj.ijo.0801605 – ident: S0007114508143604_ref23 doi: 10.1016/0003-9861(72)90025-2 – ident: S0007114508143604_ref36 doi: 10.1007/BF02532137 – ident: S0007114508143604_ref41 doi: 10.1016/S0031-9384(00)00321-8 – ident: S0007114508143604_ref38 doi: 10.1016/S0031-9384(01)00547-9 – ident: S0007114508143604_ref58 doi: 10.1016/j.metabol.2006.08.024 – ident: S0007114508143604_ref43 doi: 10.1016/S0031-9384(01)00594-7 – ident: S0007114508143604_ref53 doi: 10.1038/oby.2006.28 – ident: S0007114508143604_ref60 doi: 10.3727/000000003783992289 – ident: S0007114508143604_ref19 doi: 10.1111/j.1462-8902.2004.00328.x – ident: S0007114508143604_ref34 doi: 10.1089/dna.2007.0617 – ident: S0007114508143604_ref31 doi: 10.1016/0031-9384(87)90010-2 – ident: S0007114508143604_ref12 doi: 10.1016/S0899-9007(99)00212-9 – ident: S0007114508143604_ref25 doi: 10.1016/0031-9384(91)90326-J – volume: 251 start-page: R840 year: 1986 ident: S0007114508143604_ref5 article-title: Fatty acid oxidation and glucose utilization interact to control food intake in rats publication-title: Am J Physiol – ident: S0007114508143604_ref6 doi: 10.1016/S0163-1047(87)90112-9 – ident: S0007114508143604_ref49 doi: 10.1271/bbb.67.1999 – ident: S0007114508143604_ref46 doi: 10.1038/sj.ijo.0800965 – ident: S0007114508143604_ref48 doi: 10.1016/j.physbeh.2006.04.005 – ident: S0007114508143604_ref57 doi: 10.1152/ajpgi.00428.2004 – ident: S0007114508143604_ref3 doi: 10.1093/ajcn/62.5.1107S – ident: S0007114508143604_ref56 doi: 10.1152/ajpendo.00582.2003 – volume: 259 start-page: E650 year: 1990 ident: S0007114508143604_ref8 article-title: Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ publication-title: Am J Physiol – ident: S0007114508143604_ref52 doi: 10.1017/S0007114507659054 – volume: 82 start-page: 437 year: 1999 ident: S0007114508143604_ref32 article-title: Blood glucose and meal patterns in time-blinded males, after aspartame, carbohydrate, and fat consumption, in relation to sweetness perception publication-title: Br J Nutr doi: 10.1017/S0007114599001695 – ident: S0007114508143604_ref51 doi: 10.3177/jnsv.48.128 – ident: S0007114508143604_ref13 doi: 10.1038/sj.ijo.0801979 – volume: 25 start-page: 133 year: 2005 ident: S0007114508143604_ref20 article-title: Efficacy of a novel calcium/potassium salt of ( − )-hydroxycitric acid in weight control publication-title: Int J Clin Pharmacol Res |
| SSID | ssj0008109 |
| Score | 2.048861 |
| Snippet | The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or... The role of NEFA in eating behaviour is still poorly known. Our objective was to examine whether etomoxir (ETO), an inhibitor of NEFA oxidation, or ( -... |
| SourceID | proquest pubmed pascalfrancis crossref istex fao cambridge |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1867 |
| SubjectTerms | ( − )-Hydroxycitrate 3-Hydroxybutyric Acid 3-Hydroxybutyric Acid - blood Adult analysis Analysis of Variance Appetite Area Under Curve Biological and medical sciences Biomarkers Biomarkers - blood Blood Blood Glucose Blood Glucose - analysis blood plasma Citrates Citrates - pharmacology diet dinner drug effects drug evaluation Eating Eating behavior eating habits Energy Intake enzyme inhibitors Epoxy Compounds Epoxy Compounds - pharmacology etomoxir Fatty acid oxidation fatty acids Fatty Acids, Nonesterified Fatty Acids, Nonesterified - metabolism Feeding. Feeding behavior food intake Fundamental and applied biological sciences. Psychology ghrelin Ghrelin - blood glucose Humans Hunger hydroxycitrate Hypoglycemic Agents Hypoglycemic Agents - pharmacology ideal body weight insulin Insulin - blood lactates Lactic Acid Lactic Acid - blood Leptin Leptin - blood Lipid Metabolism Lipid Metabolism - drug effects lipogenesis lipolysis lunch Male men metabolism NEFA non-essential fatty acids Oxidation pharmacology Satiation Satiation - drug effects satiety Single-Blind Method Triglycerides Triglycerides - analysis Vertebrates: anatomy and physiology, studies on body, several organs or systems Young Adult |
| Title | Acute effects of pharmacological modifications of fatty acid metabolism on human satiety |
| URI | https://www.cambridge.org/core/product/identifier/S0007114508143604/type/journal_article https://api.istex.fr/ark:/67375/6GQ-19R45H94-6/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/19079943 https://www.proquest.com/docview/213830811 https://www.proquest.com/docview/20687766 https://www.proquest.com/docview/46347161 https://www.proquest.com/docview/67419734 |
| Volume | 101 |
| WOSCitedRecordID | wos000267772500020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Agricultural Science Database customDbUrl: eissn: 1475-2662 dateEnd: 20241212 omitProxy: false ssIdentifier: ssj0008109 issn: 0007-1145 databaseCode: M0K dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1475-2662 dateEnd: 20241212 omitProxy: false ssIdentifier: ssj0008109 issn: 0007-1145 databaseCode: 7X7 dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1475-2662 dateEnd: 20241212 omitProxy: false ssIdentifier: ssj0008109 issn: 0007-1145 databaseCode: 7RV dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1475-2662 dateEnd: 20241212 omitProxy: false ssIdentifier: ssj0008109 issn: 0007-1145 databaseCode: BENPR dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Research Library customDbUrl: eissn: 1475-2662 dateEnd: 20241212 omitProxy: false ssIdentifier: ssj0008109 issn: 0007-1145 databaseCode: M2O dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1475-2662 dateEnd: 20241212 omitProxy: false ssIdentifier: ssj0008109 issn: 0007-1145 databaseCode: 8C1 dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoy4ELb9pQWHxAPSAiktix4xMqpaUSYikLRXuLHMdGK3aTZZNF9N8zk9eqQt0LF0tJxlZsfx5_zkxmCHmpMxYok8ExlceRz7M49hXQDF9YYP-O5UFgdZNsQo7HyXSqLjrfnKpzq-x1YqOo89LgN_I3UQhnKdi_wrfLXz4mjULjapdBY4fsYdZshLmcDuctEO48PDAOYsjj3qjZRIzGvRXugRBnAtO0bUIrXNuidpwugbjimP9Bx0ldwdi5NunFzay02Z3O7v1nv-6Tux0tpcctjh6QW7Z4SLz3M1vTI9rFDp3TcR-6_xGZHpt1bWnnDkJLR5ebINiN8KLM0Q2p_SKIAk7X9RXVZpbTha0BfPNZtaBlQZs8gRTdimx99Zhcnp1-Ozn3uywNvomFrP1QGAVwRHuu4EJbxxOeGWONdlolzgV54tA4a6zIgHxYlkUiMnmstLSJTgx7QnaLsrAHhObQoLROO6Y0HFMz_A-dBZnOmQgz7pRHXg-TlHZrrUpbPzWZ_jOnHgn6eUxNF_EcE2_Mt1V5NVRZtuE-tgkfADhS_QPUcXr5NUIjcChiCWrSI0cNYoZG9OonutDJOBUfvqShmvD4XPFUeGR0DVJDhSgUAthw5JHDHjebLg-g8ciL4SnoBTT26MKWaxAJRCKlEDdLcMGAmYgtbQigm0oy6Oh-C-7NmKhAKsXZ061vd0jutMY34UfJM7Jbr9b2ObltftezajWCxTr5PmqWbFMmUCYn4YjsvTsdX0zg6lPwEcvo81-910UA |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BQkuvKGh0PoAPSAiEsex4wNCFaW0allerbS31HFstGJ3s-xmgf1R_EfGea0q1L31wHUzttb2eB6ZL_MBPFNZFEidYZrKYuqzLI59iWGGzw1G_zbKg8CoimxC9HpJvy8_rcGf9lsYB6tsbWJlqPNCu3fkr2iIuRT6r_DN5IfvSKNccbVl0Ki14tgsfmHGNnt9tI_H-5zSg3enbw_9hlTA1zEXpR9yLXH3XPmRM66MZQnLtDZaWSUTa4M8sa6WqA3P0FeaKKOc6jyWSphEJTrCedfhGnOJkEMK0o-d4U_CBlHi-i6GLG6LqFWHaufL8TcUYhF3tHDLVg4XXOK6VQUGyu6MfzugpprhWdmaZOPyKLjyhge3_7N9vAO3mrCb7NX35C6smfE98PYHpiS7pOmNOiS9lprgPvT39Lw0pIG7kMKSybLJdyU8KnIHs6rfeDoBq8pyQZQe5GRkSrxcw8FsRIoxqXgQiYNNmXLxAM6uZKEPYWNcjM0mkBwnFMYqG0mFaXjmvrOPgkzlEQ8zZqUHLzulSBtbMktrHJ5I_9EhD4JWb1LddHR3xCLDVUNedEMmdTuTVcKbqIyp-obuJj37Sl2RO-SxQDfgwW6lod0kavrdQQRFnPL3n9NQfmHxoWQp92D7ggp3A2jIOUb71IOtVk-XS-6U1IOd7inaPVfMUmNTzFEk4IkQnF8uwXiEkRdfMQfHcFqKCBf6qL5Myz2RgZCSRY9X_rsduHF4-uEkPTnqHW_BzbrQyH2aPIGNcjo3T-G6_lkOZtPtylAQOL_qG_UXuc2fGg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFH_aOoS48A0Lg80H2AERLR-OHR8QGnRj01BVBpN6yxzHRhVtU9oU6J_Gf8dzvqoJrbcduCbPVmy_T79f3gN4KdPQEyrFMJVGgUvTKHIFuhku0-j9mzDzPC3LZhO814sHA9HfgD_NvzAWVtnoxFJRZ7myd-QHgY-xFNov_8DUqIh-9_jd9IdrG0jZRGvTTaPikDO9_IXR2_ztaReP-lUQHB99_XDi1g0GXBUxXrg-UwJ30qYiGWVSGxrTVCmtpJEiNsbLYmPzikqzFO2mDtOABSqLhOQ6lrEKcd5N2OLoY9AObL0_6vXPWzMQ-zW-xFZh9GnUpFTLetXWsuMzJKIhs03iVoUdrhjITSNzdJvtif-2sE05x5MzVcuN633i0jYe3_uPd_U-3K0dcnJYSdAD2NCTh-B0h7og-6SumjoivaZpwSMYHKpFoUkNhCG5IdNV-e-SeJxnFoBV3YVaAiOLYkmkGmZkrAsUu9FwPib5hJQdEokFVOli-RgubmShT6AzySd6G0iGE3JtpAmFxAA9tX_gh14qs5D5KTXCgTctgyS1lpknFUKPJ__wkwNew0OJqmu925Yjo3VDXrdDplWhk3XE28iYifyGhii5-BLY9LfPIo4GwoH9klvbSeTsuwUP8ihhHz8nvjin0YmgCXNg9wo7twMCnzGMAwIHdhqeXS25ZVgH9tq3qBFtmktOdL5AEo_FnDN2PQVlIfpkbM0cDB1twUNc6NNKsFZ7IjwuBA2frf26PbiNgpR8Ou2d7cCdKgPJ3CB-Dp1ittAv4Jb6WQzns91aaxC4vGmR-gsnAqk3 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+effects+of+pharmacological+modifications+of+fatty+acid+metabolism+on+human+satiety&rft.jtitle=British+journal+of+nutrition&rft.au=Gatta%2C+Blandine&rft.au=Zuberbuehler%2C+Christine&rft.au=Arnold%2C+Myrtha&rft.au=Aubert%2C+Roberte&rft.date=2009-06-28&rft.issn=0007-1145&rft.volume=101&rft.issue=12+p.1867-1877&rft.spage=1867&rft.epage=1877&rft_id=info:doi/10.1017%2FS0007114508143604&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1145&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1145&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1145&client=summon |